ICON Central Laboratories ‘Stands Out As Service Provider That Is More Often Than Not Exceeding Sponsors’ Expectations’
ICON Central Laboratories - a division of ICON plc, (NASDAQ:ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries - today announced results from a recent global industry research report indicating that it ‘stands out as the service provider that is more often than not exceeding sponsors’ expectations’.
‘The State of the Central Labs Market’ report, published by Industry Standard Reports (ISR), examines the underlying dynamics of the central laboratory services market and provides an analysis of the key factors influencing satisfaction in central laboratories relationships by comparing the strengths and weaknesses of the top seven global central laboratories by market share. Its findings are based on data generated from 105 survey respondents from 75 unique sponsor companies, all with decision-making authority for central laboratories services.
The report found that ICON Central Laboratories currently exceeds all competitors in three key areas: sample turnaround times, geographic coverage and high value at low cost. According to the report, ICON Central Laboratories ‘have focused their delivery on a core set of tests and are providing them with a high degree of quality coupled with excellent project management capabilities.’ The report goes on to say, ‘ICON is separating itself from its peers in terms of the traditional cost/ value matrix, [by]… meeting expectations for low cost while performing very well and delivering high value.’
Commenting on the report, Tom O’Leary, President, ICON Central Laboratories, said, “We’re delighted with the findings of Industry Standard Research’s latest report which demonstrates that here at ICON Central Laboratories, we continue to outperform our competitors in key areas such as sample turnaround times, geographic coverage and high value at low cost. We’re particularly pleased with the finding that we’re the top rated central laboratory services provider for meeting customers’ quality and project management expectations. This finding reflects quality improvement initiatives we have put in place for our customers such as Six Sigma methodologies and MCC metrics for quality and timeliness.”
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV